The Use of Three‐Dimensional Shape and Electrostatic Similarity Searching in the Identification of a Melanin‐Concentrating Hormone Receptor 1 Antagonist
暂无分享,去创建一个
[1] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[2] Leach,et al. The in silico world of virtual libraries. , 2000, Drug discovery today.
[3] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[4] James G. Nourse,et al. Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..
[5] Mark D. McBriar,et al. Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity , 2004, Expert opinion on investigational drugs.
[6] D. E. Clark,et al. A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor. , 2004, Journal of medicinal chemistry.
[7] Anthony Nicholls,et al. Variable selection and model validation of 2D and 3D molecular descriptors> , 2004, J. Comput. Aided Mol. Des..
[8] Tudor I. Oprea,et al. Integrating virtual screening in lead discovery. , 2004, Current opinion in chemical biology.
[9] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[10] Robin Shapiro,et al. Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. , 2005, Bioorganic & medicinal chemistry letters.
[11] Robin Shapiro,et al. Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity. , 2005, Journal of medicinal chemistry.